通过基于结构的虚拟查发现了新型甲氨基基转移酶2A (MAT2A) 的全抑制剂
Tuomo Kalliokoski1, Henna Kettunen2, Esa Kumpulainen1
1Orion Pharma, Orionintie 1A, 02101 Espoo, Finland.
Bioorganic & medicinal chemistry letters
|August 17, 2023
概括
研究人员确定了针对癌症治疗的新型化学物质系列,其目标是甲氨基基基转移酶2A (MAT2A). 这些化合物显示出有前途的纳米分子活性,有助于未来对MAT2A的药物发现工作.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 氨基氨基转移酶2A (MAT2A) 是癌症治疗的验证药物标.
- 目前正在进行的临床试验正在调查MAT2A抑制剂的瘤学适用性.
研究的目的:
- 为了识别具有MAT2A抑制活性的新型化学系列.
- 支持正在进行的针对MAT2A的药物发现项目.
主要方法:
- 一个商业化学图书馆的基于结构的虚拟选.
- 使用X射线晶体学确认化合物结合模式.
- 生物化学MAT2A抑制试验和细胞增殖试验 (MTAP-/-细胞系).
主要成果:
- 发现了两种新的MAT2A抑制剂的化学系列.
- 化合物在生物化学测试中表现出纳米分子活性.
- 化合物在细胞增殖试验中显示出单位微分子活性.
- 鉴定的化合物的物理化学特性是可以接受的.
结论:
- 这些已识别的化合物代表了开发新型MAT2A抑制剂的有希望的起点.
- 生成的结构数据可以指导药物发现计划的进一步优化.
- 这些发现有助于开发针对MAT2A.的新瘤治疗药物.
更多相关视频
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.6K
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
9.6K
相关概念视频
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Regulation
58.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.2K
